Emmessar Biotech Nutrition Ltd vs Jubilant Ingrevia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Emmessar Biotech & Nutrition Ltd is ₹ 24.34 as of 20 Mar 15:30 . The P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Jubilant Ingrevia Ltd changed from 76.6 on March 2021 to 40.9 on March 2025 . This represents a CAGR of -11.79% over 5 years The Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Jubilant Ingrevia Ltd changed from ₹ 4158 crore on March 2021 to ₹ 10350 crore on March 2025 . This represents a CAGR of 20.01% over 5 years The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 1060 crore as compare to the Sep '25 revenue of ₹ 1131 crore. This represent the decline of -6.29% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 122.91 crore as compare to the Sep '25 ebitda of ₹ 146.25 crore. This represent the decline of -15.96% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Jubilant Ingrevia Ltd changed from ₹ 48.74 crore to ₹ 46.9 crore over 7 quarters. This represents a CAGR of -2.17% The Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jubilant Ingrevia Ltd changed from 14.45 % on March 2021 to 30.24 % on March 2025 . This represents a CAGR of 15.92% over 5 years .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

About Jubilant Ingrevia Ltd

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh.
The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services.

FAQs for the comparison of Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd

Which company has a larger market capitalization, Emmessar Biotech & Nutrition Ltd or Jubilant Ingrevia Ltd?

Market cap of Emmessar Biotech & Nutrition Ltd is 12 Cr while Market cap of Jubilant Ingrevia Ltd is 9,313 Cr

What are the key factors driving the stock performance of Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd?

The stock performance of Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd?

As of March 23, 2026, the Emmessar Biotech & Nutrition Ltd stock price is INR ₹24.34. On the other hand, Jubilant Ingrevia Ltd stock price is INR ₹584.7.

How do dividend payouts of Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd compare?

To compare the dividend payouts of Emmessar Biotech & Nutrition Ltd and Jubilant Ingrevia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.